The Top Deals In Health Care Corporate Finance, August 1-14, 2006

Intranasal Therapeutics, Inc., focused on developing nasally delivered, preservative-free drug products, will use the proceeds of a recent $39.1 million financing to launch its proprietary hydromorphone nasal spray for acute pain and to continue trials of its intranasal formulation of lorazepam, a benzodiazepine used for treating seizures and anxiety. Investors in the round include SV Life Sciences, Burrill & Company, Tullis-Dickerson, Fidelity Biosciences, Apjohn Ventures, Fort Washington Capital, Commonwealth Seed Capital and Kentucky Co-Investment Partners.

IntraPace, Inc. announced the closed of its $30 million Series D financing, with investors including Vulcan Capital, L Capital Partners, DFJ ePlanet Ventures, Oxford Bioscience Partners, Toucan Capital, Guidant Corporation, Johnson & Johnson Development Corp., CB Health Ventures, Halo Fund II and The Angel’s Forum. The company is developing an endoscopically delivered, implantable stimulator for the treatment of obesity and will use the proceeds from this financing to complete product development and worldwide clinical studies.

Among recent IPO filings by health care companies, Emergent BioSolutions, a biopharmaceutical company focused on the development, manufacture and commercialization of immunobiotics, filed for an initial public offering of up to $86.3 million. Emergent operates in the biodefense and commercial sectors, and manufactures and markets the only vaccine approved by the FDA for the prevention of anthrax infection. JPMorgan and Cowen & Company are the lead underwriters. Also recently, ActivBiotics, Inc. filed for an initial public offering of up to $46 million, led by HSBC, Needham & Company and BMO Capital Markets. ActivBiotics, Inc. is focused on the discovery, development and commercialization of therapies for the treatment of inflammatory diseases and bacterial infections. The proceeds of the offering are expected to be used for clinical trials and other research and development activities.

Click here for a FREE TRIAL to the Healthcare Corporate Finance News

VC Blog Archive

Back to top